Achieve Life Sciences (ACHV) Other Non-Current Liabilities (2010 - 2026)

Achieve Life Sciences (ACHV) has 12 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 2.58% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 2.58% YoY) and the FY2025 annual result came in at $1.6 million, up 35.51% from the prior year.
• Other Non-Current Liabilities slipped to $1.3 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.6 million in Q4 2025 to a low of $528000.0 in Q4 2023.
• A 4-year average of $957750.0 and a median of $924000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities jumped 117.61% — and 2026, when it gained 2.58%.
• Tracing ACHV's Other Non-Current Liabilities over 4 years: stood at $528000.0 in 2023, then soared by 117.61% to $1.1 million in 2024, then surged by 35.51% to $1.6 million in 2025, then slipped by 18.3% to $1.3 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $1.3 million (Q1 2026), $1.6 million (Q4 2025), and $1.2 million (Q1 2025), per Business Quant data.